Saratoga Advantage Trust has recently submitted its NPORT-P filing, providing key insights into its financial status and investment strategies. This filing, dated October 29, 2026, is significant as it showcases the trust's total assets exceeding $11 million, along with detailed information about its investments in the health and biotechnology sectors.

The NPORT-P filing is a crucial regulatory requirement for investment companies, designed to enhance transparency and provide investors with vital information about fund performance and holdings. For Saratoga Advantage Trust, this filing underscores its commitment to maintaining compliance with industry regulations while offering a clear view of its financial health.

Background

Saratoga Advantage Trust, an investment entity incorporated in Delaware, focuses on managing funds and investments. The trust's recent filings include multiple NPORT-P submissions, all dated October 29, 2026. The trust operates under SEC file number 811-08542 and has a fiscal year ending on August 31.

What the Filing Says

The NPORT-P filing indicates that as of August 31, 2026, Saratoga Advantage Trust holds total assets of $11,615,313.61, with total liabilities amounting to $61,520.90. This results in net assets of $11,553,792.71. The filing also details the investment strategy, highlighting a focus on health and biotechnology sectors.

Among the key investments listed are major corporations such as Medpace Holdings Inc., Regeneron Pharmaceuticals Inc., and McKesson Corp. The filing notes specific balances and values for these investments, indicating a diversified approach within the health and biotechnology portfolio.

Impact

This filing may influence various stakeholders, including investors and other investment firms. Investors looking at Saratoga Advantage Trust can gain insights into the trust's financial stability and strategic focus, particularly in the health and biotechnology sectors. Competitors in the investment industry may also analyze these developments to benchmark their performance and strategies against Saratoga Advantage Trust.

What's Next

The filing does not specify what happens next for Saratoga Advantage Trust. However, continued monitoring of its financial disclosures and performance will be essential for stakeholders interested in the trust's future developments.